Literature DB >> 30246326

Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial.

H Z Ling1, G P Guy1, A Bisquera2,3, L C Poon1,4, K H Nicolaides1, N A Kametas1.   

Abstract

OBJECTIVE: To compare maternal hemodynamics and perinatal outcome, in pregnancies that do not develop pre-eclampsia (PE) or deliver a small-for-gestational-age (SGA) neonate, between those identified at 11-13 weeks' gestation as being screen positive or negative for preterm PE, by a combination of maternal factors, mean arterial pressure, uterine artery pulsatility index, serum placental growth factor and pregnancy associated plasma protein-A.
METHODS: This was a prospective longitudinal cohort study of maternal cardiovascular function, assessed using a bioreactance method, in women undergoing first-trimester screening for PE. Maternal hemodynamics and perinatal outcome were compared between screen-positive and screen-negative women who did not have a medical comorbidity, did not develop PE or pregnancy-induced hypertension and delivered at term a live neonate with birth weight between the 5th and 95th percentiles. A multilevel linear mixed-effects model was used to compare the repeated measures of cardiac variables, controlling for maternal characteristics.
RESULTS: The screen-negative group (n = 926) had normal cardiac function changes across gestation, whereas the screen-positive group (n = 170) demonstrated static or reduced cardiac output and stroke volume and higher mean arterial pressure and peripheral vascular resistance with advancing gestation. In the screen-positive group, compared with screen-negative women, birth-weight Z-score was shifted toward lower values, with prevalence of delivery of a neonate below the 35th , 30th or 25th percentile being about 70% higher, and the rate of operative delivery for fetal distress in labor also being higher.
CONCLUSION: Women who were screen positive for impaired placentation, even though they did not develop PE or deliver a SGA neonate, had pathological cardiac adaptation in pregnancy and increased risk of adverse perinatal outcome.
Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bioreactance; cardiac output; fetal growth restriction; hemodynamic; peripheral vascular resistance; placental insufficiency; pre-eclampsia screening

Mesh:

Substances:

Year:  2019        PMID: 30246326     DOI: 10.1002/uog.20125

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  Doppler Ultrasound Imaging Combined with Fetal Heart Detection in Predicting Fetal Distress in Pregnancy-Induced Hypertension under the Guidance of Artificial Intelligence Algorithm.

Authors:  Su Liu; Yue Sun; Na Luo
Journal:  J Healthc Eng       Date:  2021-10-08       Impact factor: 2.682

Review 2.  Phenotype-Directed Management of Hypertension in Pregnancy.

Authors:  Kelsey McLaughlin; John W Snelgrove; Laura E Sienas; Thomas R Easterling; John C Kingdom; Catherine M Albright
Journal:  J Am Heart Assoc       Date:  2022-03-14       Impact factor: 6.106

Review 3.  Maternal Low Volume Circulation Relates to Normotensive and Preeclamptic Fetal Growth Restriction.

Authors:  Wilfried Gyselaers; Christoph Lees
Journal:  Front Med (Lausanne)       Date:  2022-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.